Anti-Type2-Antibodies Specifically Inhibit Murine Asthma Features Induced by Intranasal Application of IL-5 and IL-13
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2015.12.239
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2016
Authors
Publisher
Elsevier BV